Table 4. Selected NanoBRET Follow-Up.
| IC50 values (nM)a |
||||||
|---|---|---|---|---|---|---|
| compound | BMP2K | CSF1R | LRRK2 | MYLK2 | NUAK1 | TYK2 |
| 3 | >10000 | |||||
| 6 | 1020 | 7010 | ||||
| 12 | >10000 | |||||
| 13 | 3000 | >10000 | ||||
| 15 | 3670 | |||||
| 16 | >10000 | >10000 | ||||
| 19 | 5060 | >10000 | ||||
| GSK8612 | >10000 | >10000 | ||||
Compounds tested in singlicate (n = 1) in dose–response.